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CD103+CD11b+ dendritic cells (DCs) represent the
majormigratory DC population within the small intes-
tinal lamina propria (SI-LP), but their in vivo function
remains unclear. Here we demonstrate that intestinal
CD103+CD11b+ DC survival was dependent on inter-
feron regulatory factor 4 (IRF4). Mice with a DC dele-
tion in Irf4 displayed reduced numbers of intestinal
interleukin 17 (IL-17)-secreting helper T 17 (Th17)
cells and failed to support Th17 cell differentiation
in draining mesenteric lymph nodes (MLN) following
immunization. The latter was associated with a
selective reduction in CD103+CD11b+ MLN DCs
and DC derived IL-6. Immunized Il6/ mice failed
to support Th17 cell differentiation in MLN in vivo
and CD103+CD11b+ MLN DCs supported IL-6-
dependent Th17 cell differentiation in vitro. Together,
our results suggest a central role for IRF4-depen-
dent, IL-6 producing CD103+CD11b+ DCs in intesti-
nal Th17 cell differentiation.
INTRODUCTION
The intestinal mucosa represents the largest surface of the body
and is continually exposed to foreign antigen derived from our
diet and the estimated 1014 microorganisms residing within the
intestinal lumen (Goto and Kiyono, 2012; Honda and Takeda,
2009). Maintenance of intestinal homeostasis is dependent
upon the immune system’s ability to remain tolerant to these
antigens while retaining the ability to mount appropriate immune
responses to pathogens that utilize the intestine as a primary site
of entry. Importantly, a breakdown in such mechanisms is
believed to contribute to the development and maintenance of
inflammatory bowel diseases including Crohn’s disease and
ulcerative colitis, as well as food hypersensitivities such as celiac
disease (for reviews, see Meresse et al., 2009; Xavier and
Podolsky, 2007 and Abraham and Medzhitov, 2011).958 Immunity 38, 958–969, May 23, 2013 ª2013 Elsevier Inc.Dendritic cells (DCs), as key initiators and regulators of
mucosal adaptive immune responses, play an important role
in maintaining intestinal homeostasis (Coombes and Powrie,
2008; Persson et al., 2010). The integrin aE(CD103)b7 is
expressed on the majority of DCs in the intestinal lamina propria
(LP) (Johansson-Lindbom et al., 2005), from where they migrate
constitutively in afferent lymph to the mesenteric lymph nodes
(MLN) (Cerovic et al., 2012; Jaensson et al., 2008; Schulz
et al., 2009). Such steady-state migration of intestinal DCs is
believed to be important in initiating T cell responses to soluble
luminal antigen (Coombes et al., 2007; Jaensson et al., 2008)
and in establishment of oral tolerance (Scott et al., 2011; Worbs
et al., 2006). Intestinal CD103+ DCs can be divided into two ma-
jor subsets, CD103+CD11b+ and CD103+CD11b DCs, that
differ in terms of their location, transcription factor requirements
and in vitro functions (Persson et al., 2010). CD103+CD11b
DCs are the dominant CD103+ DC population in the colon LP
and similar cells are found in extraintestinal peripheral tissues
(Helft et al., 2010). Like CD8+ lymph node (LN)-resident DCs,
their development depends on the transcription factors DNA-
binding protein inhibitor (Id2), interferon (IFN) regulatory factor
8 (IRF8) and basic leucine zipper transcription factor ATF-like
3 (Batf3) (Aliberti et al., 2003; Edelson et al., 2010; Hildner
et al., 2008; Kusunoki et al., 2003; Schiavoni et al., 2002;
Tamura et al., 2005). In contrast, CD103+CD11b+ DCs are the
major DC subset in the small intestinal lamina propria (SI-LP)
(Bogunovic et al., 2009; Ginhoux et al., 2009; Schulz et al.,
2009), are rare in other peripheral tissues and they develop
independently of Id2, IRF8, or Batf3 (Edelson et al., 2010; Gin-
houx et al., 2009). Although some recent studies have assessed
the function of intestinal CD103+CD11b+ and CD103+CD11b
DCs in vitro (Cerovic et al., 2012; Denning et al., 2011; Fujimoto
et al., 2011; Rivollier et al., 2012), their roles in intestinal adap-
tive immune responses in vivo and the transcriptional factors
involved in CD103+CD11b+ DC development are currently
unknown.
Here we show that IFN regulatory factor 4 (IRF4) was required
for the development of intestinal CD103+CD11b+ DCs in vivo.
We further demonstrate a role for IRF4-dependent DCs in
the generation of the intestinal T helper 17 (Th17) cell
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Figure 1. SI-LP CD103+CD11b+ DCs Share
Phenotypic Characteristics with Splenic
CD4+ DCs
(A) Representative histograms of DCIR2 and
SIRPa expression on SI-LP and MLN CD103+
CD11b+ (solid line) and CD103+CD11b (shaded)
DCs or splenic CD4+ (solid line) and CD8a+
(shaded) DCs. Dashed line; isotype control. For
pregating, see Figure S1.
(B) SI-LP CD103+CD11b and CD103+CD11b+
DC and splenic CD4+ and CD8a+ DC numbers
8–12 days after s.c. injection of Flt3L-secreting
melanoma cells. Results are mean (SD) of five
mice from one representative experiment of two
performed.
(C) CD103+CD11b+ and CD103+CD11b- DCs from
SI-LP and splenic CD4+ and CD8a+ DCs were
assessed for Irf4 and Irf8 expression by real-time
PCR. Results are mean (SD) of 3–5 experiments
using cells pooled from 4–6 mice/experiment.
(D) IRF4 protein expression by SI-LP and splenic
DC subsets in WT (clear lines) or Irf4/ (shaded)
mice. Results are from one representative experi-
ment of three using pooled cells from 2–4 mice per
experiment. *p < 0.05, **p < 0.01, ***p < 0.001.
Immunity
CD103+CD11b+ DCs in Mucosal Th17 Differentiationcompartment and provide evidence that CD103+CD11b+ DC-
derived interleukin-6 (IL-6) was important for Th17 cell differenti-
ation in intestinal draining MLN.
RESULTS
Small Intestinal CD103+CD11b+ DCs Share Phenotypic
Characteristics with Splenic CD4+ DCs
Similar to CD103+CD11b+ SI-LP DCs, a major subset of CD4+
splenic DCs that coexpress CD11b develop independently of
IRF8, Batf3, and Id2 (Aliberti et al., 2003; Hildner et al., 2008;
Kusunoki et al., 2003; Schiavoni et al., 2002; Tamura et al.,
2005). We thus assessed whether intestinal CD103+CD11b+
DCs resembled splenic CD4+CD11b+ DCs in other aspects.
Like splenic CD4+ DCs (Dudziak et al., 2007; Matozaki et al.,
2009), CD103+CD11b+ DCs from SI-LP and MLN expressed
higher amounts of the C-type lectin, dendritic cell inhibitory
receptor (DCIR)2, and SIRPa than their CD11b (CD8a+) coun-
terparts (Figure 1A, for pregating, see Figure S1 available online).
SI-LP CD103+CD11b+ DCs also displayed limited in vivo expan-
sion to exogenous FMS-like tyrosine kinase-3 (Flt3) (Figure 1B),
as previously shown for splenic CD4+ DCs (O’Keeffe et al.,
2002). Given these observations, we assessed whether CD103+
CD11b+ DCs in SI-LP expressed IRF4, a transcription factor
required for CD4+ splenic DC development (Suzuki et al., 2004;
Tamura et al., 2005). Consistent with previous studies (Suzuki
et al., 2004; Tamura et al., 2005), splenic CD4+ and CD8a+
DCs expressed high quantities of IRF4 and IRF8 messenger
RNA (mRNA), respectively (Figure 1C). Whereas SI-LP CD103+
CD11b DCs expressed IRF8 and only low amounts of IRF4
mRNA, CD103+CD11b+ DCs expressed IRF4 and not IRF8
mRNA (Figure 1C). SI-LP CD103+CD11b+ DCs also expressed
IRF4 protein (Figure 1D). Together, these results suggest that
CD103+CD11b+ DCs are developmentally related to CD4+
splenic DCs.Identification of Putative CD103+CD11b+ DC
Equivalents in the Human SI-LP
Next we sought to identify putative equivalents to IRF4 express-
ing CD103+CD11b+ DCs in the human SI-LP. Consistent with
recent studies (Beitnes et al., 2011), CD103+ DCs were readily
identified in human SI-LP by immunohistochemistry and in
SI-LP cell preparations by flow cytometry (Figures 2A and 2B).
These cells could be readily distinguished from intestinal
macrophages by their lack of CD14 and CD163 expression (Fig-
ure 2B, data not shown). CD141 expression identifies a subset of
human DCs proposed to represent the equivalent to IRF8-
dependent murine DCs (Bachem et al., 2010; Crozat et al.,
2010; Jongbloed et al., 2010; Poulin et al., 2010; Robbins
et al., 2008). As in mice, CD103+ DCs in human intestine could
be split into two major subsets, a dominant population of
SIRPahiCD141 DCs and a minor population of CD141+
SIRPalo/ DCs (Figure 2C), the latter also expressing DNGR1
(Figure 2C), a marker expressed on Batf3-dependent DCs in
lymphoid and nonlymphoid tissues (Poulin et al., 2010, 2012).
SI-LP CD103+SIRPahi but not CD103+SIRPalo/ DCs expressed
intracellular IRF4 protein (Figure 2D). These results suggest that
CD103+SIRPahi DCs in human SI-LP represent the human equiv-
alent of murine CD103+CD11b+ DCs.
Intestinal CD103+CD11b+ DCs Are Dependent on IRF4
To determine whether the development of intestinal CD103+
CD11b+ DCs is dependent on IRF4, Irf4fl/fl (Klein et al., 2006)
mice were crossed with Cd11c-cre mice (Caton et al., 2007)
and Cd11c-cre.Irf4fl/WT progeny were backcrossed to IRF4fl/fl
mice. Genotypic analysis of Cre+ offspring showed that many
of thesemice wereCd11c-cre.Irf4fl/, demonstrating that Cre re-
combinase expression under the CD11c promoter could induce
deletion of the Irf4fl allele in germline. We thus backcrossed
Cd11c-cre.Irf4fl/ or Cd11c-cre.Irf4fl/fl animals with Irf4fl/fl mice
generating litters of Cd11c-cre.Irf4fl/fl, Cd11c-cre.Irf4fl/, Irf4fl/,Immunity 38, 958–969, May 23, 2013 ª2013 Elsevier Inc. 959
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Figure 2. Identification of Putative CD103+
CD11b+ DC Equivalents in Human SI-LP
(A) Healthy human ileum (n = 4) was stained with
antibodies to CD103, HLADR, and CD11c. Single-
color stains of insert (white box) are shown on the
right. Arrows depict examples of CD103+ DCs.
Scale bar represents 30 mm.
(B) Gating strategy to identify SI-LP CD103+ DCs.
PI, propidium iodide. Lineage cocktail (Lin) con-
tains antibodies against CD3, CD19, CD20, CD56,
and TCRab.
(C) CD103+ DCs were assessed for expression of
SIRPa, CD141, and DNGR1. One representative
staining of 3–5 intestinal tissues is shown.
(D) Intracellular IRF4 expression by SI-LP CD103+
DC subsets. One representative staining of five
intestinal tissues is shown.
Immunity
CD103+CD11b+ DCs in Mucosal Th17 Differentiationand Irf4fl/fl mice for analysis (examples of genotyping are shown
in Figure S2A). Further analysis of the Irf4 floxed locus in these
animals can be found in the Supplemental Information and
Figure S2.
To confirm that IRF4 was deleted in DCs fromCre+ mice, intra-
cellular staining for IRF4 protein was performed on splenic DCs
(Figure S3A). IRF4 protein was present in DCs from IRF4fl/
and IRF4fl/fl mice, but was not detectable in DCs from Cd11c-
cre.Irf4fl/ or Cd11c-cre.Irf4fl/fl mice. Deletion of IRF4 in Cre+
DCs was confirmed by real-time PCR (Figure S3B). In contrast,
IRF4 expression in plasma cells, which express high amounts
of IRF4 (Sciammas et al., 2006), was unaffected in Cre+ mice
(Figure S3A). We next assessed the impact of IRF4 deficiency
on DC number and subset composition. Similar results were ob-
tained between Cd11c-cre.Irf4fl/ and Cd11c-cre.Irf4fl/fl mice,
and between Irf4fl/ and Irf4fl/fl mice, and these groups were
pooled as Cre+ and Cre groups. The total number of splenic
DCs in Cre+ mice was reduced by approximately 40% (Fig-
ure S3C). Cre+ mice displayed a significant and selective reduc-
tion in CD4+ splenic DCs (Figure S3C), whereas the numbers of
other conventional DC subsets, T and B cells, or plasmacytoid
DCs in the spleen did not differ from Cre mice (Figures S3C
and S3D). In the SI-LP there was an approximate 50% reduction
in the number of CD103+CD11b+ DCs in Cre+ mice, whereas
the number of CD103+CD11b DCs and CD11c+CD103
MHCII+CD11b+ cells, the majority of which are tissue resident
macrophages (Bain et al., 2012; Schulz et al., 2009), remained
unchanged (Figures 3A and 3B). In the MLN the total DC number
was reduced by approximately 35% in Cre+ mice (Figure 3C).
Major histocompatibility class II molecule (MHCIIint) LN resident
CD11b+ DCs were reduced by approximately 50% in Cre+ mice,
whereas the numbers of LN resident CD8a+ DCs remained
unchanged (Figures 3D and 3E, for pregating strategy see Fig-960 Immunity 38, 958–969, May 23, 2013 ª2013 Elsevier Inc.ure S3E). MHCIIhi SI-LP derivedmigratory
DCs in the MLN consisted of three major
subsets, CD103+CD11b+ DCs, CD103+
CD11b DCs, and a minor population of
CD103 DCs that exhibit variable expres-
sion of CD11b (Figure 3F, for pregating
strategy see Figure S3E). Cre+ mice dis-
played a 90% reduction in CD103+CD11b+ MLN DCs compared with Cre mice, whereas CD103+
CD11b DC numbers remained unaltered (Figures 3F and 3G).
We also observed a slight reduction in CD103 MHCIIhi cells.
Together these results identify an important role for IRF4 in
intestinal CD103+CD11b+ and MLN-resident CD11b+ DCs
homeostasis in vivo.
IRF4 Is Required for Intestinal CD103+CD11b+ DC
Survival
IRF4 has recently been implicated in regulating CCR7 expres-
sion on CD11b+ dermal DCs and their subsequent migration to
skin-draining LNs (Bajana et al., 2012). A defect in SI-LP CD103+
CD11b+ DC migration alone seemed an unlikely explanation for
the dramatic reduction in MLN CD103+CD11b+ DCs in Cre+
mice as these animals had reduced numbers of SI-LP CD103+
CD11b+ DCs (Figure 3B). We thus took advantage of the fact
that deletion of the Irf4 floxed allele leads to expression of green
fluorescent protein (GFP) (Klein et al., 2006; Figure S2B) and
cocultured sorted SI-LP CD103+CD11b+ DCs from Cd11c-
cre.Irf4fl/fl (GFP+ cells) and Irf4fl/fl (GFP cells) cells in vitro for
14 hr and assessed survival and chemokine receptor CCR7
expression by flow cytometry. Whereas SI-LP CD103+CD11b+
DCs from Cre+ and Cre mice expressed CCR7 (Figure 3H),
DCs from Cre+ mice had a significant survival disadvantage
in vitro (Figure 3I). Further, MLN CD103+CD11b+ DCs in Cre+
mice displayed a marked increase in Annexin V+ cells (Figures
3J and 3K). Together, these results suggest that IRF4 plays an
important role in intestinal CD103+CD11b+ DC survival. Finally,
CD103+CD11b+ DCs were observed in the SI-LP of Irf4/
mice (Figure S3F). Thus IRF4 is not critical for the generation of
these cells, although our results do not rule out potential addi-
tional roles for IRF4 in promoting intestinal CD103+CD11b+ DC
development.
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Figure 3. Intestinal and MLN CD103+CD11b+ DCs Are Reduced in CD11cCre.IRF4fl/– and CD11cCre.IRF4fl/fl Mice
(A and B) Representative flow cytometry plots (A) and total number (B) of SI-LP DCs in Cre+ (empty bars) and Cre (filled bars) mice. Results are the mean (SD) of
four mice per group and are from one representative experiment of three performed.
(C) Total number of MLN DCs, (E) MHCIIintCD11c+ DC subsets (G) and MLN MHCIIhiCD11c+ DC subsets, and representative flow cytometry plots (D and F). For
pregating, see Figure S3. Results are the mean (SD) of four mice per group from one representative experiment of eight performed.
(H) Representative CCR7 (solid line) and isotype control (shaded) staining of Cre and Cre+ CD103+CD11b+ DCs after 14 hr in vitro coculture. Results are
representative of four biological replicates from three independent experiments.
(I) Representative flow cytometry plots andmean (SD) of ratio between Cre (GFP) and Cre+ (GFP+) SI-LP CD103+CD11b+ DCs following in vitro coculture at the
indicated time-points. Results are from 5 biological replicates with pooled cells from 2–4 mice per replicate from three independent experiments. nb, number.
(J) Representative flow cytometry plots and (K) mean (SD) of Annexin V staining in CD103+CD11b andCD103+CD11b+DCs isolated from theMLNof Cre+ (empty
bars) and Cre (filled bars) mice.
(K) Results are from 3–4 mice per group from one representative experiment of three performed. *p < 0.05, **p < 0.01 ***p < 0.001. See also Figures S2 and S3.
Immunity
CD103+CD11b+ DCs in Mucosal Th17 DifferentiationIRF4 Dependent DCs Regulate Intestinal Th17 Cell
Homeostasis
To determine whether DC deficiency in IRF4 impacted on intes-
tinal T cell populations, we next assessed the number and func-
tionality of LP T cells in Cre+ and Cre mice (Figure 4). The totalnumbers of SI-LP, colonic, andMLNCD4+ andCD8+ T cells were
similar in Cre+ and Cre groups (Figures 4A and 4E, data not
shown). Similarly the percentages of Foxp3+, IFN-g+, and IL-
17+IFN-g+ cells amongst SI and colonic CD4+ T cells did not
differ between Cre+ and Cre mice (Figures 4B and 4C). ThereImmunity 38, 958–969, May 23, 2013 ª2013 Elsevier Inc. 961
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Figure 4. Th17 Cells Are Reduced in the Small Intestine and Colon of
Mice Lacking IRF4-Dependent DCs
(A) Total number of CD4+ T cells, (B) representative flow cytometry plots, and
(C) pooled data showing the percentages of FoxP3+, IFN-g+, IL-17+, and IFN-
g+IL-17+ CD4+ cells in the SI-LP and colon of Cd11c-cre.Irf4fl/ (filled circles),
Cd11c-cre.Irf4fl/fl (empty circles), Irf4fl/ (filled squares), and Irf4fl/fl (empty
squares) mice. Each symbol represents an individual animal, with line repre-
senting mean. Results are from two pooled experiments of three performed
with similar results. nb, number.
(D) Representative flow cytometry plots and percentage of FoxP3+CD4+ cells
expressing Helios or Neuropilin-1. Cre mice (shaded), Cre+ mice (solid line),
and isotype control (dotted line). Bars are the mean (SD) of 6–14 mice per
group from 2–4 pooled experiments.
(E) Number of CD4+ T cells and percentage of IL-17+ CD4+ T cells in the MLN
of Cd11c-cre.Irf4fl/ (filled circles), Cd11c-cre.Irf4fl/fl (empty circles), Irf4fl/
(filled squares), and Irf4fl/fl (empty squares) mice. Each symbol represents an
individual animal, with line representing mean. Results are from four pooled
experiments. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S4.
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962 Immunity 38, 958–969, May 23, 2013 ª2013 Elsevier Inc.was a minor, albeit significant, increase in the proportion of
Helios+ Foxp3+ cells within the colon of Cre+ mice; however,
this was not observed in the SI-LP or MLN or when analyzing
the proportion of neuropilin-1+ T regulatory (Tregs) cells (Fig-
ure 4D, lower histograms), indicating that Cre+ and Cre mice
contained similar proportions of natural and inducible Tregs
(Thornton et al., 2010; Weiss et al., 2012; Yadav et al., 2012). In
contrast, CD4+ cells that produced IL-17 alone were significantly
reduced in the SI-LP, colon, and MLN of Cre+ mice (Figures 4C
and 4E). This was not due to an intrinsic defect in the ability of
CD4+ T cells from Cre+ mice to produce IL-17 because naı¨ve
CD4+ T cells from Cre+ and Cremice produced similar amounts
of IL-17 when stimulated under Th17 cell polarizing conditions
in vitro (Figure S4). Together these results suggest a critical
role for IRF4-dependent DCs in the generation and/or mainte-
nance of the intestinal Th17 cell compartment.
IRF4-Dependent DCs Are Required for Th17 Cell
Differentiation in MLN
To assess whether the reduction in mucosal Th17 cells in Cre+
mice may reflect reduced priming of Th17 cells in MLN, OT-II
cells were injected i.v. into Cd11c-cre.Irf4fl/fl, Cd11c-cre.Irf4fl/,
Irf4fl/ and Irf4fl/fl mice. Oral or intraperitoneal (i.p.) immunization
with OVA alone did not induce Th17 cell differentiation in MLN
of WT mice; however, reproducible Th17 cell differentiation
occurred after i.p. immunization with OVA together with aCD40
and LPS (Figure S5), and this protocol was adopted for future
experiments. One and 3 days after immunization, mice were
injected with the sphingosine 1-phosphate receptor agonist
FTY720 i.p. to prevent effector lymphocyte egress from LNs,
and 4 days after immunization the numbers and phenotype of
responding OT-II cells assessed in MLN and spleen by flow
cytometry. OT-II responses did not differ between Cd11c-
cre.Irf4fl/ and Cd11c-cre.Irf4fl/fl recipients, or between Irf4fl/
and Irf4fl/fl recipients. The percentage of OT-II cells within the
CD45+ gate was modestly reduced in both the MLN and spleen
of Cre+ mice, reaching significance only in the MLN (Figure 5A).
Despite this, OT-II cells underwent similar rounds of division in
Cre+ andCre recipients (Figure 5B) and displayed similar down-
regulation of CD62L (Figure 5C). Similarly, responding OT-II cells
in the MLN of Cre+ and Cre mice expressed comparable
amounts of a4b7 and CCR9 (Figures 5D and 5E). Generation of
gut tropic T cells in MLN in vivo is critically dependent on the
Vitamin A metabolite, retinoic acid (RA) (Iwata et al., 2004;
Jaensson-Gyllenback et al., 2011) and CD103+ DCs have been
proposed to be an important source of this RA (Iwata et al.,
2004; Jaensson et al., 2008; Yokota et al., 2009). MLN of Cre+
mice contained DCs with aldehyde dehydrogenase activity, as
assessed by the ALDEFLUOR assay (Figure S6A). CD103+
CD11b DCs from Cre+ and Cre mice displayed similar alde-
hyde dehydrogenase activity (Figure S6B), while the few MLN
CD103+CD11b+ DCs in Cre+ mice were ALDEFLUOR (Fig-
ure S6B). To assess Th17 cell differentiation, MLN and spleen
cells were restimulated with PMA and ionomycin and OT-II cells
were analyzed for intracellular IL-17 (Figures 5F and 5G). OT-II
cells primed in the MLN of Cre+ mice displayed a striking reduc-
tion in IL-17+ cells (Figures 5F and 5G). In contrast, the percent-
age of IL-17 expressing OT-II cells in the spleen of both Cre+ and
Cre mice was low (Figure 5G). The percentages of IFN-g
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Figure 5. IRF4 Dependent DCs Are Required
for Th17 Cell Differentiation In Vivo
(A–H) Following OT-II cell transfer, recipient mice
were immunized i.p. with OVA, aCD40, and LPS.
One and three days later, mice received FTY720
i.p. and animals were sacrificed 4 days after im-
munization. (A) Percentage of OT-II cells among
CD45+ cells in the MLN and spleen of Cd11c-
cre.Irf4fl/ (filled circles), Cd11c-cre.Irf4l/fl (empty
circles), Irf4fl/ (filled squares), and Irf4fl/fl (empty
squares) mice. Each symbol represents an indi-
vidual animal, with line representing mean. Results
are from three independent experiments per-
formed. (B) Representative CFSE profile of OT-II
cells in the MLN of Cre+ (blue line) and Cre (red
line) mice. (C) Percentage of CD62L expressing
OT-II cells in the MLN. Non-imm, non-immunized.
Imm, immunized. Results are from one (non-imm)
or two (imm) pooled experiments performed. (D)
Representative flow cytometry plots and (E) pooled
data of gut homing receptor expression on OT-II
cells in the MLN. Results are pooled from four
experiments. (F-H) Spleen and MLN cells were
restimulated with PMA and ionomycin and IL-17
and IFN-g producing OT-II cells identified by
intracellular cytokine staining. (F) Representative
intracellular IL-17 staining of OT-II cells from MLN
and pooled (G) IL-17 and (H) IFN-g expression data
fromMLN and spleen. Results are pooled from 2–3
experiments.
(I) Lethally irradiated WT mice were reconstituted
with Cd11c-cre.Irf4fl/ or Irf4fl/ BM (100%) or with
a 50:50 mixture of Cd11c-cre.Irf4fl/ or Irf4fl/ BM
together with Rag1/ BM (50%). OT-II cells were
injected into indicated BM chimeras and recipients
immunized as above. Representative flow cy-
tometry plots from one of three or four mice per
group from one representative experiment of two
performed. **p < 0.01, ***p < 0.001. See also Fig-
ures S5 and S6.
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CD103+CD11b+ DCs in Mucosal Th17 Differentiationproducing OT-II cells in the MLN and spleen did not differ signif-
icantly between Cre+ and Cremice (Figure 5H). OT-II cells failed
to differentiate into Th17 cells in the MLN of irradiated WT mice
reconstitutedwith Cre+ bonemarrow; however, this was rescued
by complementation with Rag1/ BM (Figure 5I). Together,
these results suggest an important role for IRF4-dependent
DCs in Th17 cell differentiation in MLN.
CD103+CD11b+ DCs Drive Th17 Cell Differentiation
in MLN
To identify the potential mechanism underlying impaired Th17
cell differentiation in MLN of Cre+ mice, the number and subset
composition of DCs in adjuvant-treated Cre+ and Cre mice
was compared (Figures 6A–6C). Adjuvant administration re-Immunity 38, 958–sulted in increased numbers of MLN DCs
compared to steady state (Figure 6A,
compare with Figure 3E). As observed
under steady-state conditions (Figure 3E),
adjuvant-treated Cre+ mice had signifi-
cantly fewer DCs in the MLN compared
with Cre mice (Figure 6A). All MLN DCs
from stimulated mice had high expression of MHCII, and thus it
was no longer possible to distinguish between resident and
migratory DC subsets (Figure 6B). Nevertheless, DCs could be
divided into four major subsets based on expression of CD103
and CD11b (Figure 6B). None of these cells expressed the
FcgR1 receptor CD64 (data not shown), indicating that they
were conventional and not monocyte-derived DCs (Langlet
et al., 2012). Although CD103+CD11b+ DCs represented the
major DC population in the MLN of adjuvant-injected Cre
mice, their numbers were dramatically and significantly reduced
in Cre+ mice (Figures 6B and 6C). In contrast, the number of
CD103+CD11b, CD103CD11b, and CD103CD11b+ DCs
did not differ between Cre+ and Cre mice (Figures 6B and
6C). To determine which MLN DC subsets could induce Th17969, May 23, 2013 ª2013 Elsevier Inc. 963
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Figure 6. CD103+CD11b+ DCs Drive Th17 Cell Differentiation in MLN
(A–C) Cre+ (empty bars) and Cre (filled bars) mice were injected with aCD40 and LPS i.p. and 17 hr later MLN DC numbers (A) and subset composition (B and C)
was assessed by flow cytometry. Lin contains antibodies against CD3, CD19, and NK1.1. (B) Representative flow cytometry plots and (A and C) mean (SD) of
three mice from one representative experiment of three performed.
(D–F) DC subsets were sorted from theMLN of (D and E)WT or (F) Cre andCre+mice 17 hr after aCD40 and LPS injection and culturedwith naı¨ve OT-II cells in the
presence of (D and F) OVA or (E) plate-bound aCD3. (D) Total OT-II cell number and (D–F) IL-17 concentrations in culture supernatants were assessed after 4 days
culture. Results are the mean (SEM) of 2–5 independent experiments with 1–4 biological replicates per experiment.
(G and H) DC subsets were sorted from (G) MLN or (H) SI-LP of (G and H) untreated or (G) aCD40 and LPS treated WT mice, cultured with naı¨ve OT-II cells in the
presence of OVA or (H) OVA and ODN 1668 and IL-17 concentrations assessed as above. Results are mean (SEM) of 3–8 biological replicates using pooled cells
from 2–10 mice per replicate from 4–5 independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001.
Immunity
CD103+CD11b+ DCs in Mucosal Th17 Differentiationcell differentiation in vitro, we sorted them from adjuvant-treated
mice, cultured them with naı¨ve OT-II cells in the presence of
OVA, and measured IL-17 concentrations in culture superna-
tants 4 days later (Figure 6D). Although similar numbers of
T cells were recovered from the cultures, IL-17 was only
detected in OT-II cultures containing CD103+CD11b+ or
CD103CD11b+ MLN DCs (Figure 6D). Selective induction of
IL-17 by CD103+CD11b+ or CD103CD11b+ MLN DCs was not
due to differences in TCR signaling, because these remained
the only subsets that induced IL-17 production when OVA was
replaced with plate bound aCD3 (Figure 6E). CD103CD11b+
MLN DCs from adjuvant-treated Cre+ induced even higher IL-
17 production in OT-II cells compared with CD103CD11b+
DCs from Cre mice (Figure 6F), demonstrating that IRF4 defi-
ciency did not inhibit the ability of DC to induce Th17 cell differ-964 Immunity 38, 958–969, May 23, 2013 ª2013 Elsevier Inc.entiation. Together, these results suggest that deficiency in
Th17 cell differentiation in Cre+ mice in vivo is due to a lack of
CD103+CD11b+ DCs.
To assess the requirement for inflammatory stimuli in the abil-
ity of CD103+CD11b+ DCs to generate Th17 cells in vitro,
CD103+CD11b+ and CD103+CD11b DCs were sorted from
the MLN and SI-LP of untreated mice, cultured with OT-II cells
and IL-17 concentrations assessed as above. MLN CD103+
CD11b+ DCs induced limited IL-17 production compared with
CD103+CD11b+ DCs from aCD40 and LPS treated animals (Fig-
ure 6G). Consistent with previous results (Denning et al., 2011),
SI-LP CD103+CD11b+ DCs induced Th17 cell differentiation in
the steady state (Figure 6H). However, it should be noted that
exhaustive procedures are required to isolate these cells, which
likely include unavoidable exposure to luminal derived microbial
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Figure 7. CD103+CD11b+ DCs Are an Impor-
tant Source of IL-6 that Is Required for Th17
Cell Differentiation in MLN
(A) DCs were sorted from the MLN 17 hr after i.p.
injection of aCD40 and LPS and gene expression
assessed by real-time PCR. Results are from four
experiments with each symbol representing DCs
from a single mouse. Horizontal line represents
mean.
(B and C) Sorted DC subsets (B, 5 3 104 cells; C,
2.53 104 cells) from adjuvant treated (B) WT or (C)
Cre+ and Cre mice were cultured for (B) 24 hr or
(C) 24 and 48 hr and the concentration of IL-6 in
culture supernatants assessed by CBA. Results
are (B) the mean (SEM) of 7–9 biological replicates
per group from four independent experiments or
(C) mean (SEM) from one experiment with three
biological replicates per group.
(D and E) OT-II cells were adoptively transferred
into WT or Il6/ mice, recipient mice were
immunized as in Figure 5 and IL-17 production by
OT-II cells in the MLN assessed 4 days later. (D)
Representative flow cytometry plots and (E) per-
centage of IL-17+ OT-II cells in MLN. Results are
from one independent experiment of three per-
formed with 1–4 mice per group. Horizontal line
represents mean.
(F) CD103+CD11b+ DCswere sorted from theMLN
of aCD40 and LPS treated mice and cultured
together with naı¨ve OT-II cells in the presence of
OVA and aIL-6 or isotype antibody. Results are the
mean (SEM) of four independent experiments with
1–4 biological replicates per experiment. *p < 0.05,
**p < 0.01, ***p < 0.001. See also Figure S7.
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CD103+CD11b+ DCs in Mucosal Th17 Differentiationproducts, as well as necrotic epithelial cells. Thus, whether
these results reflect the true steady-state activity of SI-LP DCs
remains unclear. Because aCD40 and LPS administration in-
duces CD103+CD11b+ DC migration from the SI-LP to the
MLN, we instead assessed whether TLR ligation enhanced the
capacity of SI-LP CD103+CD11b+ DCs to induce Th17 cell differ-
entiation by addition of the TLR9 agonist ODN 1668 to the cocul-
tures. Such activation led to a significant increase in IL-17
production (Figure 6H). Together with our in vivo findings (Fig-
ure S5) these results suggest that intestinal CD103+CD11b+
DCs require inflammatory signals to efficiently promote Th17
cell differentiation.
CD103+CD11b+ DCs Are an Important Source of IL-6
that Is Required for Th17 Cell Differentiation in MLN
To address why reduced numbers of CD103+CD11b+ DCs lead
to a lack of Th17 cell differentiation in MLN, we sorted total
MLN DCs from adjuvant-injected Cre+ and Cre mice and
analyzed for expression of IL-1b, TGF-b, IL-6, IL-23, and avb8 in-
tegrin; factors that have been implicated in mucosal Th17 cell
development (Hu et al., 2011; Ivanov et al., 2006; Mangan
et al., 2006; Melton et al., 2010; Shaw et al., 2012). Expression
of IL-1b and TGF-b mRNA and protein and b8 integrin mRNA
did not differ in MLN DCs from Cre and Cre+ mice, whereas
IL-23 mRNA was barely detectable (Figure 7A, Figure S7). In
contrast, IL-6 mRNA expression was reduced by approximately
60% in MLN DCs from Cre+ compared with Cre mice (Fig-
ure 7A). Consistent with these findings, CD103+CD11b+ MLNDCs were a major source of IL-6 in adjuvant-treated WT mice
(Figure 7B). CD103CD11b+ MLN DCs also produced IL-6 (Fig-
ure 7B); however, CD103CD11b+ MLN DCs from adjuvant-
treated Cre+ mice produced as much IL-6 as CD103CD11b+
MLN DCs from Cre mice (Figure 7C), demonstrating that the
reduction in DC-derived IL-6 in Cre+ mice was not due to defec-
tive IL-6 production by these cells but rather the selective
reduction in CD103+CD11b+ DCs. Importantly IL-6 was required
for Th17 cell differentiation in MLN as immunized Il6/ mice
failed to support efficient OT-II development into Th17 cells (Fig-
ures 7D and 7E). Finally, neutralizing IL-6 antibody blocked the
ability of CD103+CD11b+ MLN DCs to induce Th17 cell differen-
tiation in vitro (Figure 7F). Together, these results suggest that
IL-6-producing CD103+CD11b+ DCs play a central role in driving
Th17 cell differentiation in MLN.
DISCUSSION
CD103+CD11b+ DCs are the major migratory DC subset in the
SI-LP, but the factors regulating their development and function
remain largely unknown. Here we have demonstrated that SI-LP
and MLN CD103+CD11b+ DC survival was dependent on the
transcription factor IRF4, and identified a putative IRF4-express-
ing CD103+SIRPa+ DC equivalent in the human SI-LP. Th17 cell
numbers were significantly reduced in the intestine of mice lack-
ing IRF4-dependent DCs, and Th17 cell differentiation in draining
MLN was severely perturbed in these animals. Mechanistic
studies suggested a critical role for CD103+CD11b+ DC-derivedImmunity 38, 958–969, May 23, 2013 ª2013 Elsevier Inc. 965
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CD103+CD11b+ DCs in Mucosal Th17 DifferentiationIL-6 in driving Th17 cell differentiation in MLN. Together, these
results suggest a central role for IRF4-dependent DC in the
generation of mucosal Th17 cell responses.
Previous studies in mice with a genetic deletion in IRF4 have
indicated a role for IRF4 in splenic CD4+ DC development
(Suzuki et al., 2004; Tamura et al., 2005). Consistent with this
finding, we found that IRF4 deletion in CD11c+ cells led to a
reduction in splenic CD4+ DCs, as well as lymph-node-resident
CD8CD11b+ DCs. In addition, we demonstrated that intestinal
CD103+CD11b+ DCswere IRF4-dependent and thus represent a
peripheral tissue DC subset that is developmentally related to
lymphoid tissue Batf3 and IRF8-independent DCs. Recently,
mice with a DC deletion in Notch-2 were shown to have reduced
numbers of CD4+ splenic and CD103+CD11b+ DC in SI-LP
(Lewis et al., 2011), providing a potential additional develop-
mental link between these populations. Mice with a DC-specific
deletion in Notch-2 have an increased percentage of
CD11bCD8 double-negative splenic DCs expressing either
SIRPa or CD24 (Lewis et al., 2011), representing putative imme-
diate precursors of CD11b+ and CD8+ DCs, respectively (Lewis
et al., 2011). However, we did not observe an accumulation of
such cells in mice whose DCs lacked IRF4, indicating an involve-
ment for IRF4 subsequent to Notch-2 signaling, at least in the
spleen. In addition to IRF4 and Notch-2, TNF receptor-associ-
ated factor-6 (TRAF-6), IRF2, and Rel-B are required for
CD11b+ lymphoid-resident DC homeostasis (Ichikawa et al.,
2004; Kobayashi et al., 2003; Wu et al., 1998). Whether these
pathways are involved in intestinal CD103+CD11b+ DC homeo-
stasis, as well as the link between these pathways, the Notch-
2 pathway and IRF4 remains to be determined.
CD103+ DCs have been proposed to provide an important
source of RA (Iwata et al., 2004; Jaensson et al., 2008; Mora
et al., 2006; Yokota et al., 2009) that is critical in driving ‘‘gut
homing’’ receptor expression on MLN-primed T cells in vivo
(Iwata et al., 2004; Jaensson-Gyllenback et al., 2011). Despite
the severe reduction in CD103+CD11b+ MLN DCs, Cre+ mice
had similar numbers of intestinal T cells and induction of CCR9
and a4b7 onMLN-primed CD4+ T cells as Cremice. Consistent
with these findings, a similar proportion of MLN DCs from immu-
nized Cre+ and Cre mice possessed aldehyde dehydrogenase
activity, and thus the ability to metabolize retinal to RA. Because
the few remaining CD103+CD11b+MLNDCs in Cre+mice lacked
aldehyde dehydrogenase activity, our results collectively sug-
gest that CD103+CD11b+ MLN DC-derived RA is dispensable
for the generation of ‘‘gut tropic’’ T cells, as well as intestinal
FoxP3+-inducible Treg cell development (Coombes et al.,
2007; Sun et al., 2007) in vivo. CD103+CD11b MLN DCs in
Cre+ and Cre mice displayed similar aldehyde dehydrogenase
activity and thus may provide an alternative source of RA within
the MLN. However intestinal T cells in Batf3/mice, which lack
CD103+CD11b MLN DCs, also express CCR9 and a4b7 (Edel-
son et al., 2010). Thus, RA-derived from either IRF4-dependent
or Batf3-dependent DCs or potentially non-DC derived RA, for
example from MLN stromal cells (Hammerschmidt et al., 2008;
Molenaar et al., 2009), may be sufficient to generate ‘‘gut
homing’’ T cell populations in vivo.
Th17 cells are abundant in the intestinal mucosa where they
are thought to play an important role in maintaining epithelial
integrity and protection against bacterial and viral pathogens966 Immunity 38, 958–969, May 23, 2013 ª2013 Elsevier Inc.(Maloy and Kullberg, 2008). However, the DC subsets involved
in the generation and maintenance of mucosal Th17 cell
responses in vivo has remained unclear. Here we have demon-
strated that reduction in intestinal CD103+CD11b+ DCs is asso-
ciated with a selective reduction in mucosal Th17 cells. Although
a similar phenotype was reported recently in mice with a
DC-specific deletion in Notch 2 (Lewis et al., 2011), we here
extend these findings, demonstrating a major defect in Th17
cell differentiation in the MLN of immunized mice that selectively
lacked CD103+CD11b+ DCs.
Previous studies have demonstrated that activated SI-LP
CD103+CD11b+ DCs are more efficient than CD103+CD11b
DCs at inducing Th17 cell differentiation in vitro (Denning et al.,
2011; Fujimoto et al., 2011; Uematsu et al., 2008) and that intes-
tinal lymph derived CD103-CD11b+ but not CD103+CD11bDCs
can induce Th17 cell differentiation (Cerovic et al., 2012). Consis-
tent with these studies, we found that only CD103+CD11b+ and
CD103CD11b+ MLN DCs from adjuvant-treated mice induced
Th17 cell differentiation in vitro. Importantly, CD103CD11b+
MLN DCs from adjuvant treated Cre+ mice were fully capable
of generating Th17 cells in vitro. Thus the inability of immunized
Cre+mice to support Th17 cell differentiation in theMLN in vivo is
not because IRF4 is required to imprint CD103CD11b+ DCs
with a Th17 cell polarizing capacity but rather due to the lack
of CD103+CD11b+ DCs.
In contrast to CD103+CD11b+ MLN DCs from adjuvant-
treated mice, CD103+CD11b+ MLN DCs from unmanipulated
mice were poor at inducing Th17 cell differentiation in vitro.
These results are consistent with a report by Cerovic et al. exam-
ining the activity of CD103+CD11b+ DCs isolated from steady-
state intestinal lymph (Cerovic et al., 2012) and, together with
our in vivo observation that OT-II cells fail to differentiate into
Th17 cells after immunization with OVA alone, suggest that
inflammatory signals are important to induce an efficient Th17
cell-polarizing capacity in CD103+CD11b+ DCs.
Recent studies have suggested key roles for IL-1b (Hu et al.,
2011; Shaw et al., 2012), TGF-b (Mangan et al., 2006), avb8
(Melton et al., 2010), and IL-6 (Hu et al., 2011; Ivanov et al.,
2006) in intestinal Th17 cell development. Here we found that
MLN DCs in adjuvant-treated Cre+ mice had a selective 60%
reduction in the amount of IL-6 mRNA compared with Cre
mice. However, this is likely an underestimate of the differences
in DC-derived IL-6 in vivo, because MLN DC numbers are
also reduced by 50% in Cre+ mice. CD103+CD11b+ and
CD103CD11b+ DCs were the major source of DC-derived
IL-6; however, because CD103CD11b+ DCs from Cre+ and
Cremice produced similar amounts of IL-6, these data strongly
suggest that the reduction in DC-derived IL-6 in Cre+ mice is due
to the loss of CD103+CD11b+ DCs. Similar to mice with a DC
deficiency in IRF4, Il6/ mice have reduced numbers of intesti-
nal Th17 cells (Hu et al., 2011) and we here extended these
findings, demonstrating that IL-6 plays a central role in driving
Th17 cell differentiation in MLN in vivo. Moreover the ability of
CD103+CD11b+ DCs to drive Th17 cell differentiation in vitro
was IL-6-dependent. Collectively, our results implicate a role
for CD103+CD11b+ DC-derived IL-6 in driving mucosal Th17
cell differentiation.
The lack of Th17 cell priming in MLN offers a plausible expla-
nation for the reduced numbers of endogenous intestinal Th17
Immunity
CD103+CD11b+ DCs in Mucosal Th17 Differentiationcells in Cre+ mice and suggest that intestinal LP Th17 cell in the
steady-state may result from historical differentiation events
mediated by activated rather than semimature CD103+CD11b+
DCs. Our results do not, however, exclude the possibility that
DCs help maintain Th17 cell numbers once in the intestinal LP.
In this regard, IL-1b production by SI-LP CD11cF4/80+ macro-
phages has been implicated in maintaining intestinal Th17 cells
(Shaw et al., 2012), and SI-LP CD103+CD11b+ DCs were
recently shown to rapidly produce IL-23 following i.p. adminis-
tration of flagellin (Kinnebrew et al., 2012).
Collectively, our findings identify a key role for IRF4-depen-
dent IL-6-producing CD103+CD11b+ DCs in the induction of
intestinal Th17 cell responses. These observations are likely to
have important implications for mucosal vaccine design and
for the development of novel therapies to treat Th17 cell-
mediated inflammatory disease.
EXPERIMENTAL PROCEDURES
Mice and Human Tissues
B6.129S1-Irf4tm1Rdf/J (Klein et al., 2006), Itgax-Cre (Cd11c-Cre) (Caton et al.,
2007), C57BL/6, B6.129P-CX3CR1tm1Litt/J (Jung et al., 2000), B6.Cg-
Tg(TcraTcrb)425Cbn/J (OT-II).CD45.1, and Rag1/ mice were maintained
at the Biomedical Center, Lund or Clinical Research Center, Malmo¨. IL-6-defi-
cient (B6.129S2-Il6tm1Kopf/J) mice and their relevant controls were from the
Jackson Laboratory. Where indicated, DCs were expanded in vivo by injecting
Flt3L-secreting B16 melanoma cells (Mach et al., 2000) as described previ-
ously (Schulz et al., 2009). Human terminal ileum was obtained from patients
undergoing cystectomy with bladder reconstruction. Animal experiments
were performed in accordance with the Lund/Malmo¨ Animal Ethics Com-
mittee, and human tissues were obtained with informed patient consent and
in accordance with the Regional Ethics committee in Lund, Sweden.
Cell Isolation
Murine Cell Isolation
Cell suspensions of SI-LP, colon, MLN, and spleen were generated as
described previously (Jaensson et al., 2008), occasionally replacing Collage-
nase VIII with Liberase TM (0.2–0.3 WunchU/ml, Roche).
Human Intestinal Cell Isolation
Underlying muscular layers and fat were removed, remaining tissue was cut
into small (<5 mm) pieces, and epithelial cells were removed as described
for murine tissues (Jaensson et al., 2008). Remaining tissue fragments were
either (1) digested for 2 3 60 min at 37C in RPMI 1640 (Gibco, Invitrogen),
supplemented with 10% FCS (Sigma Aldrich), 10 mM HEPES, 1 mM sodium
pyruvate, 100 U/ml Penicillin, and 100 mg/ml Streptomycin (all from Gibco,
Invitrogen) (R10 medium) containing Liberase TM (0.13 WunchU/mL, Roche)
and DNAse I (20 IU/mL, Sigma) with magnetic stirring and cell suspensions
pooled after filtering through 100 and 70 mM cell strainers or (2) placed in
2 ml of R10 medium in ultra low attachment 24 well culture plate (Sigma-
Aldrich) for 18 hr at 37C in 5% CO2 (Mahida et al., 1997) and migrating cells
collected for further analysis.
Flow Cytometry
Flow cytometry was performed according to standard procedures. Dead cells
(propidium iodide+) and cell aggregates (identified on FSC-A versus FSC-W
scatterplots) were excluded from all analyses. Data acquisition was performed
on a FACSAria or LSRII (BD Biosciences) and analyzed by using FlowJo soft-
ware (Tree Star).
Adoptive Transfers
OT-II cells were labeled with CFSE according to standard protocols, and we
intravenously (i.v.) injected 33 106 cells into each mouse. After 24 hr, recipient
mice were immunized i.p. with ovalbumin (OVA, 0.5 mg) together with aCD40
(25 mg, Biolegend) and LPS (20 mg). One and 3 days later, mice were injected
with FTY720 (1 mg/kg body weight; Cayman) in saline i.p., and 4 days afterimmunization, animals were sacrificed and donor T cells (CD45.1+ CD4+
Va2+) analyzed by flow cytometry. To generate bone marrow (BM) chimeras,
we transferred BM cells (1.5 3 106) from the indicated mice into irradiated
(900 rad) recipient mice by i.v. injection. Mice were used in OT-II adoptive
transfer experiments after 6–8 weeks.
Cell Culture
For intracellular cytokine analysis, SI-LP and colon cells were stimulated with
PMA (50 ng/ml) and ionomycin (500 ng/ml) andMLN cells with PMA (100 ng/ml)
and ionomycin (1 mg/ml). Brefeldin A (10 mg/ml for intestinal cells, 20 mg/ml for
MLN cells) was added after 1 hr, and cells were harvested 4 hr later and stained
for the indicated cytokines. For DC T cell cocultures, naive OT-II cells (13 105)
were cultured with the indicated DC subset (53 104) (except in Figures 6G and
6H where half the number of DC and T cells were used) in the presence of
plate-bound aCD3 (145-2C11; 10 mg/ml) or OVA (1 mg/ml) for 4 days. Where
indicated, aIL-6 (5 mg/ml, MP5-20F3), isotype control (5 mg/ml, RTK2071), or
ODN 1668 (1 mM, InvivoGen) was added to the cultures. Concentrations of
IL-17 in cell supernatants were assessed by CBA (BD Bioscience).
Statistical Analysis
Statistical significance was estimated by using GraphPad Prism software
(GraphPad), with paired or unpaired two-tailed Student’s t test where
appropriate.SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
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